View in EDS

Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.

Saved in:
Bibliographic Details
Title: Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.
Authors: Gisslinger H; Medical University Vienna, Department of Internal Medicine I, Division of Haematology and Blood Coagulation, Vienna, Austria., Klade C; AOP Orphan Pharmaceuticals AG, Vienna, Austria., Georgiev P; University Multiprofile Hospital for Active Treatment 'Sveti Georgi', Clinic of Hematology, Medical University of Plovdiv, Plovdiv, Bulgaria., Krochmalczyk D; University Hospital in Krakow, Teaching Unit of the Hematology Department, Krakow, Poland., Gercheva-Kyuchukova L; Multiprofile Hospital for Active Treatment 'Sveta Marina', Clinical Hematology Clinic, Varna, Bulgaria., Egyed M; Kaposi MorCounty Teaching Hospital, Department of Internal Medicine II, Kaposvar, Hungary., Rossiev V; Samara Kalinin Regional Clinical Hospital, Samara, Russia., Dulicek P; University Hospital Hradec Kralove, Department of Clinical Hematology, Hradec Kralove, Czech Republic., Illes A; University of Debrecen, Faculty of Medicine, Department of Hematology, Debrecen, Hungary., Pylypenko H; Cherkasy Regional Oncology Centre, Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy, Ukraine., Sivcheva L; Multiprofile Hospital for Active Treatment - HristoBotev, First Department of Internal Medicine, Vratsa, Bulgaria., Mayer J; University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, Czech Republic., Yablokova V; Yaroslavl Regional Clinical Hospital, Department of Hematology, Yaroslavl, Russia., Krejcy K; AOP Orphan Pharmaceuticals AG, Vienna, Austria., Hasselbalch HC; Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Denmark., Kralovics R; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria., Kiladjian JJ; Université de Paris, CIC 1427, Inserm, Paris, France and Centre d'Investigations Cliniques, AP-HP, Hospital Saint-Louis, Paris, France.
Source: HemaSphere [Hemasphere] 2020 Oct 20; Vol. 4 (6), pp. e485. Date of Electronic Publication: 2020 Oct 20 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 33134869
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gisslinger+H%22">Gisslinger H</searchLink>; Medical University Vienna, Department of Internal Medicine I, Division of Haematology and Blood Coagulation, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Klade+C%22">Klade C</searchLink>; AOP Orphan Pharmaceuticals AG, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Georgiev+P%22">Georgiev P</searchLink>; University Multiprofile Hospital for Active Treatment 'Sveti Georgi', Clinic of Hematology, Medical University of Plovdiv, Plovdiv, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Krochmalczyk+D%22">Krochmalczyk D</searchLink>; University Hospital in Krakow, Teaching Unit of the Hematology Department, Krakow, Poland.<br /><searchLink fieldCode="AU" term="%22Gercheva-Kyuchukova+L%22">Gercheva-Kyuchukova L</searchLink>; Multiprofile Hospital for Active Treatment 'Sveta Marina', Clinical Hematology Clinic, Varna, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Egyed+M%22">Egyed M</searchLink>; Kaposi MorCounty Teaching Hospital, Department of Internal Medicine II, Kaposvar, Hungary.<br /><searchLink fieldCode="AU" term="%22Rossiev+V%22">Rossiev V</searchLink>; Samara Kalinin Regional Clinical Hospital, Samara, Russia.<br /><searchLink fieldCode="AU" term="%22Dulicek+P%22">Dulicek P</searchLink>; University Hospital Hradec Kralove, Department of Clinical Hematology, Hradec Kralove, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Illes+A%22">Illes A</searchLink>; University of Debrecen, Faculty of Medicine, Department of Hematology, Debrecen, Hungary.<br /><searchLink fieldCode="AU" term="%22Pylypenko+H%22">Pylypenko H</searchLink>; Cherkasy Regional Oncology Centre, Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy, Ukraine.<br /><searchLink fieldCode="AU" term="%22Sivcheva+L%22">Sivcheva L</searchLink>; Multiprofile Hospital for Active Treatment - HristoBotev, First Department of Internal Medicine, Vratsa, Bulgaria.<br /><searchLink fieldCode="AU" term="%22Mayer+J%22">Mayer J</searchLink>; University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology, Brno, Czech Republic.<br /><searchLink fieldCode="AU" term="%22Yablokova+V%22">Yablokova V</searchLink>; Yaroslavl Regional Clinical Hospital, Department of Hematology, Yaroslavl, Russia.<br /><searchLink fieldCode="AU" term="%22Krejcy+K%22">Krejcy K</searchLink>; AOP Orphan Pharmaceuticals AG, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Hasselbalch+HC%22">Hasselbalch HC</searchLink>; Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Kralovics+R%22">Kralovics R</searchLink>; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Kiladjian+JJ%22">Kiladjian JJ</searchLink>; Université de Paris, CIC 1427, Inserm, Paris, France and Centre d'Investigations Cliniques, AP-HP, Hospital Saint-Louis, Paris, France.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2020 Oct 20; Vol. 4 (6), pp. e485. <i>Date of Electronic Publication: </i>2020 Oct 20 (<i>Print Publication: </i>2020).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=33134869
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1097/HS9.0000000000000485
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e485
    Titles:
      – TitleFull: Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gisslinger H
      – PersonEntity:
          Name:
            NameFull: Klade C
      – PersonEntity:
          Name:
            NameFull: Georgiev P
      – PersonEntity:
          Name:
            NameFull: Krochmalczyk D
      – PersonEntity:
          Name:
            NameFull: Gercheva-Kyuchukova L
      – PersonEntity:
          Name:
            NameFull: Egyed M
      – PersonEntity:
          Name:
            NameFull: Rossiev V
      – PersonEntity:
          Name:
            NameFull: Dulicek P
      – PersonEntity:
          Name:
            NameFull: Illes A
      – PersonEntity:
          Name:
            NameFull: Pylypenko H
      – PersonEntity:
          Name:
            NameFull: Sivcheva L
      – PersonEntity:
          Name:
            NameFull: Mayer J
      – PersonEntity:
          Name:
            NameFull: Yablokova V
      – PersonEntity:
          Name:
            NameFull: Krejcy K
      – PersonEntity:
          Name:
            NameFull: Hasselbalch HC
      – PersonEntity:
          Name:
            NameFull: Kralovics R
      – PersonEntity:
          Name:
            NameFull: Kiladjian JJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 10
              Text: 2020 Oct 20
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-electronic
              Value: 2572-9241
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: HemaSphere
              Type: main
ResultId 1